Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

Wellcome Trust Featured PhD Programmes
University of Kent Featured PhD Programmes
University College London Featured PhD Programmes
University College London Featured PhD Programmes
University of Manchester Featured PhD Programmes
"protein" AND "aggregatio…×
10 miles

protein aggregation PhD Projects, Programs & Scholarships

We have 27 protein aggregation PhD Projects, Programs & Scholarships

  • "protein" AND "aggregation" ×
  • clear all
Order by 
Showing 1 to 10 of 27
  (BBSRC DTP) Elucidating the responses to nascent protein misfolding and aggregation stress
  Prof C M Grant, Prof S Hubbard, Prof M Ashe
Application Deadline: 31 January 2019
The aim of this study is to characterize the proteins that aggregate during nascent protein misfolding and to investigate how cells mitigate the damaging effects of aggregate formation.
  Characterising surface properties of protein biopharmaceutical molecules
  Dr A Golovanov, Dr J Warwicker
Applications accepted all year round
Protein biologicals have great potential for the effective treatment of a wide range of diseases. However, aggregation and instability are inherent issues with all protein pharmaceuticals, which is a problem that can limit their utility and developability.
  A novel class of excipients for stabilizing protein therapeutics
  Dr R Curtis, Dr J Warwicker
Applications accepted all year round
Biopharmaceutical proteins constitute a growing proportion of the drug catalogue for virtually all major pharmaceutical companies.
  Deciphering Roles of SUMOylation in mini-Human Brains in Health and Disease
  Dr C Guo, Dr S Brown
Application Deadline: 23 January 2019
Neurodegenerative disorders and cerebral ischemia are incurable conditions, imposing tough medical challenges and a substantial economic burden on health services.
  Deep Learning / Bioinformatics Approach for Protein-Protein Interaction Prediction
  Dr JC Nebel
Applications accepted all year round
Since most molecular processes rely on protein–protein interactions PPIs), knowledge of those interactions is extremely valuable for biomedical research and drug design.
  Targeting the earliest steps in the aggregation process of the intrinsically unfolded protein alpha-Synuclein, the most validated target in Parkinson’s disease.
  Research Group: Institute of Quantitative Biology, Biochemistry and Biotechnology
  Prof M Auer, Dr T Kunath
Application Deadline: 13 December 2018
α-Synuclein is a small presynaptic protein whose aggregation and fibrillation are considered hallmarks of Parkinson’s disease.
  Predicting the conversion of LRRK2 carriers to Parkinson disease: the role of blood and CSF biomarkers
  Dr E Sammler
Applications accepted all year round
Parkinson’s disease is a progressive neurodegenerative disease affecting up to 1:500 people over the age of 50 years.1 The risk of developing Parkinson’s…
  Understanding Neuroinflammation through advanced in vitro 3D modelling using human Pluripotent Stem Cells
  Dr S Cowley, Prof W S James
Application Deadline: 25 January 2019
Microglia - brain-resident macrophages - carry out homeostatic surveillance functions in the brain, clearing dying cells, extracellular debris, and pruning synapses during development.
  Mitigating parkinsonian neurodegenerative changes in cellular and animal models of PD
  Dr M Iravani
Application Deadline: 28 December 2018
The University invites applications for a PhD student to join our Hertfordshire Knowledge Exchange Partnership (HKEP) scheme.
  Real-time monitoring of biopharmaceutical aggregation under flow by fluorescence
  Dr R Curtis, Dr C Pereira da Fonte, Dr A Pluen
Applications accepted all year round
Biopharmaceutical proteins constitute a growing proportion of the drug catalogue for virtually all major pharmaceutical companies.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.